These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9311897)

  • 21. The C-terminal domain of the pVP2 precursor is essential for the interaction between VP2 and VP3, the capsid polypeptides of infectious bursal disease virus.
    Oña A; Luque D; Abaitua F; Maraver A; Castón JR; Rodríguez JF
    Virology; 2004 Apr; 322(1):135-42. PubMed ID: 15063123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of apoptosis in vitro by the 17-kDa nonstructural protein of infectious bursal disease virus: possible role in viral pathogenesis.
    Yao K; Vakharia VN
    Virology; 2001 Jun; 285(1):50-8. PubMed ID: 11414805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fowl adenovirus recombinant expressing VP2 of infectious bursal disease virus induces protective immunity against bursal disease.
    Sheppard M; Werner W; Tsatas E; McCoy R; Prowse S; Johnson M
    Arch Virol; 1998; 143(5):915-30. PubMed ID: 9645198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phylogenetic analysis of Infectious Bursal Disease viruses according to newly proposed model of classification into geno-groups.
    Ali Khan RS; Habib M; Ali W; Salah Ud Din Shah M; Ashraf A; Ali Tahir Z; Helal ZH; Khan MI; Mahboob S; A-Al-Ghanim K; Al-Misned F
    J Infect Public Health; 2019; 12(3):410-418. PubMed ID: 30651212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens.
    Tsukamoto K; Saito S; Saeki S; Sato T; Tanimura N; Isobe T; Mase M; Imada T; Yuasa N; Yamaguchi S
    J Virol; 2002 Jun; 76(11):5637-45. PubMed ID: 11991992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The expression of IBDV VP2 in chicken primary myoblast cells using the baculovirus vector].
    Ge J; Gao D; Lou Z; Ping W
    Wei Sheng Wu Xue Bao; 2009 Sep; 49(9):1259-64. PubMed ID: 20030068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of infectious bursal disease virus replication by shRNAs targeting the VP1 and VP2 genes driven by chicken U6 promoter.
    Ouyang W; Ma JR; Wang YQ; Qin LT; Jiang JY; Fan HJ; Wang XM; Wang YS
    Vet Microbiol; 2013 Feb; 162(1):44-52. PubMed ID: 22959482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VP1, the putative RNA-dependent RNA polymerase of infectious bursal disease virus, forms complexes with the capsid protein VP3, leading to efficient encapsidation into virus-like particles.
    Lombardo E; Maraver A; Castón JR; Rivera J; Fernández-Arias A; Serrano A; Carrascosa JL; Rodriguez JF
    J Virol; 1999 Aug; 73(8):6973-83. PubMed ID: 10400796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of two strains of Marek's disease virus serotype 1 for the development of recombinant vaccines against very virulent infectious bursal disease virus.
    Li K; Liu Y; Liu C; Gao L; Gao Y; Zhang Y; Cui H; Qi X; Zhong L; Wang X
    Antiviral Res; 2017 Mar; 139():153-160. PubMed ID: 27908832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recombinant Vp2 protein of infectious bursal disease virus AH1 strain expressed in insect cells: a vaccine candidate].
    Ouyang W; Wang Y; Zhou Y; Zhang H; Tang Y
    Sheng Wu Gong Cheng Xue Bao; 2010 May; 26(5):595-603. PubMed ID: 20684302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infectious bursal disease virus polyprotein processing does not involve cellular proteases.
    Kibenge FS; Qian B; Cleghorn JR; Martin CK
    Arch Virol; 1997; 142(12):2401-19. PubMed ID: 9672603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modification of infectious bursal disease virus antigen VP2 for cell surface location fails to enhance immunogenicity.
    Heine HG; Hyatt AD; Boyle DB
    Virus Res; 1994 Jun; 32(3):313-28. PubMed ID: 8079513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue culture infectivity of different strains of infectious bursal disease virus is determined by distinct amino acids in VP2.
    Mundt E
    J Gen Virol; 1999 Aug; 80 ( Pt 8)():2067-2076. PubMed ID: 10466805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Construction and immunological characterization of recombinant Marek's disease virus expressing IBDV VP2 fusion protein].
    Liu HM; Qin AJ; Liu YL; Jin WJ; Ye JQ; Chen HJ; Shao HX; Li YX
    Sheng Wu Gong Cheng Xue Bao; 2006 May; 22(3):391-6. PubMed ID: 16755916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Avian adenovirus CELO recombinants expressing VP2 of infectious bursal disease virus induce protection against bursal disease in chickens.
    Francois A; Chevalier C; Delmas B; Eterradossi N; Toquin D; Rivallan G; Langlois P
    Vaccine; 2004 Jun; 22(17-18):2351-60. PubMed ID: 15149796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A very virulent genotype of infectious bursal disease virus predominantly associated with recurrent infectious bursal disease outbreaks in Tunisian vaccinated flocks.
    Mardassi H; Khabouchi N; Ghram A; Namouchi A; Karboul A
    Avian Dis; 2004 Dec; 48(4):829-40. PubMed ID: 15666864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection against infectious bursal disease virulent challenge conferred by a recombinant avian adeno-associated virus vaccine.
    Perozo F; Villegas P; Estevez C; Alvarado IR; Purvis LB; Williams S
    Avian Dis; 2008 Jun; 52(2):315-9. PubMed ID: 18646463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cloned Vero cell lines transfected with full-length A-segment or ORF1 cDNA sequence of IBDV.
    Ye J; Chen Q; Zhou J; Li L
    Cell Biol Int; 2007 Feb; 31(2):165-72. PubMed ID: 17137796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular determinants of virulence, cell tropism, and pathogenic phenotype of infectious bursal disease virus.
    Brandt M; Yao K; Liu M; Heckert RA; Vakharia VN
    J Virol; 2001 Dec; 75(24):11974-82. PubMed ID: 11711587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of field and vaccine infectious bursal disease viruses from Nigeria revealing possible virulence and regional markers in the VP2 minor hydrophilic peaks.
    Adamu J; Owoade AA; Abdu PA; Kazeem HM; Fatihu MY
    Avian Pathol; 2013; 42(5):420-33. PubMed ID: 23919308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.